Topics

Medtronic PLC Strategy, SWOT and Corporate Finance Report [Report Updated: 23102018] Prices from USD $154

10:50 EST 4 Dec 2019 | BioPortfolio Reports

Medtronic PLC Strategy, SWOT and Corporate Finance Report


Summary


Medtronic PLC Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Medtronic PLC Medtronic or 'the company' is a medical technology and services company. The company manufactures, develops and markets medical devices and technologies to various customers worldwide. Medtronic serves to hospitals, clinics, thirdparty health care providers, distributors, and other institutions, such as governmental health care programs and group purchasing organizations. The company market its products across Europe, Asia Pacific, the Americas, the Middle East and Africa. Medtronic offers its products under BioGlide, ATLANTIS, autoLog, CapSure, CD HORIZON, Cardioblate, CORNERSTONESR, Keracel, LandmarX, Kappa 900 and MacroPore Channel, ENDORING, ClearView, COLORADO, Enterra, ForSite, Freestyle, Hancock, InSync, InterStim and INVISx brands. The company is headquartered in Dublin, Ireland.


Scope


Detailed information on Medtronic PLC required for business and competitor intelligence needs

A study of the major internal and external factors affecting Medtronic PLC in the form of a SWOT analysis

An indepth view of the business model of Medtronic PLC including a breakdown and examination of key business segments

Intelligence on Medtronic PLC's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Medtronic PLC, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Medtronic PLC and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Medtronic PLC as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Medtronic PLC's business structure, strategy and prospects.

Original Article: Medtronic PLC Strategy, SWOT and Corporate Finance Report [Report Updated: 23102018] Prices from USD $154

NEXT ARTICLE

More From BioPortfolio on "Medtronic PLC Strategy, SWOT and Corporate Finance Report [Report Updated: 23102018] Prices from USD $154"

Quick Search

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...